Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,664
Closed -$122K 395
2023
Q1
$122K Buy
+3,664
New +$141K 0.01% 280
2022
Q1
Sell
-1,300
Closed -$82K 484
2021
Q4
$82K Sell
1,300
-83,900
-98% -$7.11M ﹤0.01% 287
2021
Q3
$8.98M Sell
85,200
-20,000
-19% -$2.87M 0.38% 71
2021
Q2
$18.6M Sell
105,200
-21,000
-17% -$3.38M 0.75% 52
2021
Q1
$16.8M Buy
126,200
+6,700
+6% +$1.04M 0.72% 57
2020
Q4
$16.2M Buy
119,500
+16,100
+16% +$1.64M 0.72% 50
2020
Q3
$8.6M Buy
103,400
+43,600
+73% +$3.5M 0.43% 62
2020
Q2
$4.91M Buy
59,800
+47,900
+403% +$3.24M 0.32% 70
2020
Q1
$613K Buy
+11,900
New +$620K 0.05% 108

Other funds holding ZLAB

TOBAM's ZLAB Position: Q2 2023 in Review

TOBAM sold out of Zai Lab (ZLAB) in Q2 2023, closing a stake of 3,664 shares — an estimated $122K sold.

TOBAM first reported a position in ZLAB in Q1 2020 and held it in 9 quarters. The position peaked at $18.6M in Q2 2021. 137 funds tracked by Wall St. Rank hold ZLAB as of Q2 2023.

  • TOBAM reported no remaining Zai Lab position as of Q2 2023 after selling out during the quarter.
  • TOBAM sold 3,664 Zai Lab shares in Q2 2023, an estimated $122K.
  • TOBAM first reported a position in Zai Lab in Q1 2020 and held it in 9 quarters.
  • TOBAM's Zai Lab position peaked at $18.6M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Zai Lab as of Q2 2023.

Based on TOBAM's 13F filing for Q2 2023, filed 31 Jul 2023.